CXCL9 and portal hypertension: CXCL9 is involved in ALD pathogenesis by orchestrating T-cell recruitment and IFN-gamma-mediated responses [29]; this can limit fibrosis under some conditions [25], yet high CXCL9 also reflects severe disease (portal hypertension, organ dysfunction) and portends poor prognosis [30].